SHOT Annual Report 2009 - Serious Hazards of Transfusion

More documents

Recommendations

Info

ICS incidents n = 6 ■ ■ ■■ ■■ Operator errors Heparinised saline used in wrong bag, 1 case Machine errors Faulty optic – red cells spilled into waste bag, 2 cases Clinical adverse events Hypotension, 3 cases Case 1 Hypotension Patient had massive transfusion due to acute haemorrhage for placenta accreta. Allogeneic (donor) blood and intraoperative salvaged blood were transfused. Cell salvaged blood was administered and 5–10 minutes after this, the patient developed hypotension, with BP dropping from 88/25 to 61/28. The transfusion was stopped and BP returned to 90/30. Transfusion restarted and BP dropped to 66/34, with complete resolution when transfusion was again stopped. The patient had been given 3500 mL crystalloid and 4 units of allogeneic blood. Patient also had 2 or 3 episodes of hypotension prior to this event due to hypovolaemia. This year there were 5 cases of adverse reactions reported to postoperative, unwashed autologous transfusion. Previous reports to SHOT on this type of event have been sporadic but with the advent of the online reporting system it is envisaged that these reports may be a feature of future reports. In 2009 there were 3 reports of hypotension related to the reinfusion of cell salvaged blood. While an attempt has been made to analyse the clinical scenarios of each report the common factors, certainly in 2 cases, appear to be: ■■ ■■ Use of ACD as an anticoagulant Use of a leucodepletion filter (LDF) during the reinfusion of autologous washed red cells. There are a number of other clinical issues: ■■ ■■ ■■ ■■ Use of bedside LDF, which is known to cause hypotension when used with allogeneic blood as previously recognised. 54 These patients may be hypovolaemic and therefore more susceptible to the effect of reinfused vasoactive cytokines. All patients experienced transient but clinically significant hypotension, a blood pressure drop of 20% or more from the starting value, corrected by the cessation of infusion and/or vasopressors. No long term sequelae of this hypotension were noted. These phenomena will require further in-depth analysis to fully understand the consequences of such incidents. At this stage it is important to recognise this as a possible adverse event and treat by discontinuation of the infusion of salvaged red cells and with appropriate vasopressors. 138 19. Autologous Transfusion
RECOMMENDATIONS There are no new recommendations for this year. Recommendations still relevant from last year Year first made Recommendation Target Progress 2008 All cell salvage operators must undertake initial and regular update training and be assessed as competent. There should be documented evidence of competence in the form of a training record. Competency-assessment workbooks are available for both ICS and PCS at www.transfusionguidelines.org.uk Cell salvage leads /HTT Online survey currently being undertaken by the UK Cell Salvage Action Group, asking about training and competency. Education workbook produced and available on the website. 2008 All ICS and PCS related adverse events should be reported to SHOT. Cell salvage leads /HTT There is a specially designed section of the new web-based SHOT reporting system to facilitate this. 2008 Monitoring of patients is as important for the reinfusion of red cells collected by ICS or PCS as it is for allogeneic red cells. Cell salvage leads /HTT 2008 Cell salvage machines are classified as Medical Devices, so all adverse events attributable to machine errors and failures should be reported to the MHRA as well as SHOT. Cell salvage leads /HTT 19. Autologous Transfusion 139
Page 1 and 2:
Annual Report 2009 Affiliated to th
Page 3 and 4:
Requests for further information sh
Page 5 and 6:
1. Foreword The Serious Hazards of
Page 7 and 8:
2. SHOT - The UK Haemovigilance Sch
Page 9 and 10:
3. Participation in Haemovigilance
Page 11 and 12:
Figure 2 Number of reports sent per
Page 13 and 14:
For the first time this year, SHOT
Page 15 and 16:
4. SHOT 2009-2010 UK Transfusion La
Page 17 and 18:
Update on 2008 recommendations Last
Page 19 and 20:
Numbers of components issued In 200
Page 21 and 22:
Table 10 Cumulative mortality/morbi
Page 23 and 24:
Acute transfusion reaction (ATR) Th
Page 25 and 26:
6. Key Messages and Main Recommenda
Page 27 and 28:
Recommendation All pulmonary compli
Page 29 and 30:
2005 Appropriate use of blood compo
Page 31 and 32:
7. Incorrect Blood Component Transf
Page 33 and 34:
Table 12 Summary of IBCT cases Type
Page 35 and 36:
Major morbidity There were 2 cases
Page 37 and 38:
Wrong blood components transfused t
Page 39 and 40:
Learning points ■■ All componen
Page 41 and 42:
Table 15 Number of staff involved i
Page 43 and 44:
All of the errors in this group wer
Page 45 and 46:
Trust and sometimes in separate Tru
Page 47 and 48:
IBCT events originating in the hosp
Page 49 and 50:
multiple group O components; 1 grou
Page 51 and 52:
Learning points ■■ ■■ Where
Page 53 and 54:
Three interpretation errors occurre
Page 55 and 56:
IT must be used to its full potenti
Page 57 and 58:
Case 8 When the laboratory knows of
Page 59 and 60:
■■ All staff must take full pro
Page 61 and 62:
7.1 Errors Relating to IT Systems (
Page 63 and 64:
to laboratory B. The clinical reque
Page 65 and 66:
Improving Laboratory Standards (bas
Page 67 and 68:
7.2 Right Blood Right Patient (RBRP
Page 69 and 70:
COMMENTARY Each year SHOT emphasise
Page 71 and 72:
Core hours vs. out of hours and Whe
Page 73 and 74:
Broad breakdown of where primary er
Page 75 and 76:
Case 6 Dilute (possible drip arm) s
Page 77 and 78:
Case 10 Over-transfusion following
Page 79 and 80:
9. Handling and Storage Errors (HSE
Page 81 and 82:
Excessive time to complete administ
Page 83 and 84:
etween removing the component from
Page 85 and 86:
10. Adverse Events Relating to Anti
Page 87 and 88:
Omission or late administration of
Page 89 and 90:
Anti-D Ig given to the wrong patien
Page 91 and 92: RECOMMENDATIONS New recommendations
Page 93 and 94: Case 1 Possible fatal reaction A ma
Page 95 and 96: adequate resources both for monitor
Page 97 and 98: Figure 12 Reaction by component typ
Page 99 and 100: Bacterial culture of patient and un
Page 101 and 102: Previous recommendations that are s
Page 103 and 104: Figure 13 Number of cases of HTR re
Page 105 and 106: Antibody only detectable in eluate
Page 107 and 108: Table 39 Serology, laboratory signs
Page 109 and 110: Table 40 DHTRs - New specificities
Page 111 and 112: 13. Transfusion-Related Acute Lung
Page 113 and 114: Classification of cases according t
Page 115 and 116: Comparative data on implicated comp
Page 117 and 118: Case Histories TRALI probable Case
Page 119 and 120: RECOMMENDATIONS New recommendations
Page 121 and 122: Table 42 Cases classified according
Page 123 and 124: Clinical details and transfused flu
Page 125 and 126: Cases in which RBC transfusion was
Page 127 and 128: exchange in patients with TTP. 43 I
Page 129 and 130: 15. Transfusion-Associated Dyspnoea
Page 131 and 132: 16. Post-Transfusion Purpura (PTP)
Page 133 and 134: ■■ The requirement to irradiate
Page 135 and 136: Two incidents (both bacterial, desc
Page 137 and 138: Viral and parasitic TTIs Since 1996
Page 139 and 140: The most likely source of the organ
Page 141: 19. Autologous Transfusion Definiti
Page 145 and 146: Introduction and overall trends In
Page 147 and 148: incident group O D negative units w
Page 149 and 150: Table 47 Types of reactions for eac
Page 151 and 152: always require notification by clin
Page 153 and 154: 21. Near Miss Reporting Definition
Page 155 and 156: 29 UK Resuscitation Council Emergen
Page 157: 24. Acknowledgements The Steering G
show all

SHOT Annual Report 2009 - Serious Hazards of Transfusion

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?